Literature DB >> 20818871

PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.

Rolf Stahl, Elion Hoxha, Kai Fechner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20818871     DOI： 10.1056/NEJMc1003066

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

Review 1.  Idiopathic membranous nephropathy: an autoimmune disease.

Authors:  Sudesh P Makker; Alfonso Tramontano
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

2.  Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors:  Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2011-07-08

Review 3.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

4.  Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches - Per Ardua Ad Astra?

Authors:  Ana Konvalinka; Sanjeeva Srivastava; Mario Masellis
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-03-01

5.  Clinical Relevance of Domain-Specific Phospholipase A2 Receptor 1 Antibody Levels in Patients with Membranous Nephropathy.

Authors:  Linda Reinhard; Gunther Zahner; Stephan Menzel; Friedrich Koch-Nolte; Rolf A K Stahl; Elion Hoxha
Journal:  J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 10.121

6.  Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.

Authors:  Peter D Burbelo; Megha Joshi; Adrija Chaturvedi; Dustin J Little; John S Thurlow; Meryl Waldman; Stephen W Olson
Journal:  J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 10.121

7.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Authors:  Elion Hoxha; Ina Thiele; Gunther Zahner; Ulf Panzer; Sigrid Harendza; Rolf A K Stahl
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

8.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

9.  Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

Authors:  A Kattah; R Ayalon; L H Beck; S Sethi; D G Sandor; F G Cosio; M J Gandhi; E C Lorenz; D J Salant; F C Fervenza
Journal:  Am J Transplant       Date:  2015-03-12       Impact factor: 8.086

Review 10.  Rituximab therapy in nephrotic syndrome: implications for patients' management.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.